FpML-EQD v2 FpML EQD WG Agenda 1400 LDN Fri 23 May 2008

[andrew.p.parry@xxxxxxxxxxxx]

* Telephone Conference

US: 1 888 481 3032
UK: 0 800 904 7961
Intl: 1 617 801 9600

Participant code: 8682747


* Agenda

1. Actions from 1400 LDN Fri 16 May
2008

TA/JC create further Swaps Wire proposal
for inclusion in FpML-4-4-LCWD-2
MG confirm that Swaps Wire interest
leg date type proposal is consistent with existing date type
LL arrange area on FpML website to host
XQuery implementation of FpML business rules
RM contact Harry McAllister ( IRD WG
Chair ) for advice on approach to compounding spread proposal
RM create compounding spread proposal
MR provide list of business rule condition
and context
IY correct validation examples recorded
as issues 703, 704, 705, 706

2. Swaps Wire Interest Leg proposal

MG now confirms that FpML-4-3 is closed,
this work must be included in FpML-4-4 onwards

3. Swaps Wire Coding Scheme proposal

ISDA have produced a draft of the 2008
Open Market Option annex for AEJ, the following addition is propoosed for
the master confirmation type scheme ( current version is "master-confirmation-type-5-7.xml"
)

 <Row>
           
<Value>
<SimpleValue>ISDA2008EquityOptionAsiaExcludingJapan</SimpleValue>
           
</Value>
           
<Value>
           
   <SimpleValue>FpML</SimpleValue>
           
</Value>
           
<Value>
           
   <SimpleValue>The Cash-settled Open Market Equity Option
Annex to the ISDA 2008 AEJ (Asia Excluding
Japan) Master Equity
Derivatives Confirmation Agreement applies.</SimpleValue>
           
</Value>
         </Row>

4. Time scale for seperation of schema
and coding scheme values

Either a date for implementation, or
the date when we can expect a decision

This is of particular interest to this
group given the diversity of ISDA documentation we must support, which
does not always require schema changes

5. DTCC Compounding Spread Proposal

Please see attached "compounding.zip"

6. Moving second order derivatives into
FpML-4-5, Scope of FpML-4-5

I propose that we move EQD second order
derivatives ( Option on Correlation Swap, Option on Dividend Swap, Option
on Variance Swap ) into FpML-4-5, to allow time for finalised ISDA documentation,
and more input from the group

Product scope of FpML-4-5 would be

Option on Variance Swap ( ISDA draft
in progress )
Variance Swap on Dispersion Underlyer
( ISDA draft in progress )

and in addition, if there is sufficient
interest

Option on Correlation Swap
Option on Dividend Swap

other products will be added, or existing
products amended on a demand led basis

7. Issues

http://www.fpml.org/issues/view.php?id=703
http://www.fpml.org/issues/view.php?id=701
http://www.fpml.org/issues/view.php?id=699
http://www.fpml.org/issues/view.php?id=684
http://www.fpml.org/issues/view.php?id=685
http://www.fpml.org/issues/view.php?id=698
http://www.fpml.org/issues/view.php?id=700
http://www.fpml.org/issues/view.php?id=702
http://www.fpml.org/issues/view.php?id=682
http://www.fpml.org/issues/view.php?id=672
http://www.fpml.org/issues/view.php?id=686
http://www.fpml.org/issues/view.php?id=683
http://www.fpml.org/issues/view.php?id=679
http://www.fpml.org/issues/view.php?id=675
http://www.fpml.org/issues/view.php?id=677

8. AOB

Andrew Parry
+44 20 7325 1486
Exotics and Hybrids Architecture
JP Morgan

---

This communication is for informational purposes only. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice. Any comments or statements made herein do not necessarily reflect those of JPMorgan Chase & Co., its subsidiaries and affiliates. This transmission may contain information that is privileged, confidential, legally privileged, and/or exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or use of the information contained herein (including any reliance thereon) is STRICTLY PROHIBITED. Although this transmission and any attachments are believed to be free of any virus or other defect that might affect any computer system into which it is received and opened, it is the responsibility of the recipient to ensure that it is virus free and no responsibility is accepted by JPMorgan Chase & Co., its subsidiaries and affiliates, as applicable, for any loss or damage arising in any way from its use. If you received this transmission in error, please immediately contact the sender and destroy the material in its entirety, whether in electronic or hard copy format. Thank you. Please refer to http://www.jpmorgan.com/pages/disclosures for disclosures relating to UK legal entities.

Attachment: compounding.zip
Description: Zip archive